Journal
JOURNAL OF ENDOCRINOLOGY
Volume 176, Issue 3, Pages 339-348Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/joe.0.1760339
Keywords
-
Categories
Ask authors/readers for more resources
Accumulating evidence indicates that menaquinone-4 (MK-4), a vitamin K, with four isoprene units, inhibits osteoclastogenesis in murine bone marrow culture, but the reason for this inhibition is not yet clear, especially in human bone marrow culture. To clarify the inhibitory mechanism, we investigated the differentiation of colony-forming-unit fibroblasts (CFU-Fs) and osteoclasts in human bone marrow culture, to learn whether the enhancement of the differentiation of CFU-Fs from progenitor cells might relate to inhibition of osteoclast formation. Human bone marrow cells were grown in a-minimal essential medium with horse serum in the presence of MK-4 until adherent cells formed colonies (CFU-Fs). Colonies that stained positive for alkaline phosphatase activity (CFU-F/ALP+) were considered to have osteogenic potential. MK-4 stimulated the number of CFU-F/ALP+ colonies in the presence or absence of dexamethasone. The stimulation was also seen in vitamin K, treatment. These cells had the ability to mineralize in the presence of glycerophosphate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available